Aletho News


Ivermectin Study’s Negative Conclusion is at Odds With Its Findings of Significant Clinical Benefit


A new study on cheap, repurposed Covid treatment ivermectin has concluded that its findings “do not support the use of ivermectin to treat mild to severe forms of COVID-19”. However, this conclusion is at odds with its findings.

The study, “Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomised, Double-Blinded, Placebo-Controlled Clinical Trials”, is published in Frontiers in Medicine. It includes among its authors Dr. Andrew Hill, who last year appeared to suggest to Dr. Tess Lawrie that pressure had been applied to him not to find in support of ivermectin in an earlier paper. He told her, “I’m in a very sensitive position here”, and “I don’t really want to get into” revealing who from Gates-funded charity Unitaid, which funded the study, really wrote the conclusion of the paper downplaying the benefits of the treatment.

The new study gives a helpful introduction to the drug.

Ivermectin is a low-cost established drug with clinical benefits and minimal safety concerns, which has been shown to inhibit SARS-CoV-2 in vitro in studies. Ivermectin has rapid oral absorption, with high lipid solubility is widely circulated in the body, metabolised in the liver, and excreted in faeces. The adequate concentration of ivermectin inhibiting SARS-CoV-2 in the in vitro experiment is higher than the approved dose of ivermectin concentration in plasma and the lungs of humans. However, a meta-analysis demonstrated that the administration of a standard FDA-approved dose shows a positive clinical response in COVID-19 patients.

The study is a follow-up to an earlier, smaller study which showed promise. However, the promise has not, the authors say, been borne out.

Despite our previous more favourable results from a multicentre, randomised clinical trial in 69 COVID-19 patients at the beginning of the pandemic which noted the effectiveness of ivermectin in recovery and decreasing duration of hospital stay, the current results of this extensive study on 609 admitted patients with moderate to severe form of COVID-19 and 549 outpatients with a mild form of COVID-19, did not show adequate support for the effectiveness of this drug.

Despite this downbeat assessment, the new study did actually find a significant 32% improvement in ivermectin hospital patients achieving complete recovery, with 37% of ivermectin patients vs 28% of placebo patients achieving the outcome [95% CI, 1.04–1.66].

A number of the other key outcomes, including ICU admission and death, were also better in the ivermectin group, though the study was underpowered (not large enough) for these results to be statistically significant (i.e., we can’t be sure they weren’t coincidence). These were:

  • ICU admission: 28 ivermectin vs 32 placebo patients; 9% vs 11%; 16% improvement [95% CI, 0.52–1.36].
  • Invasive mechanical ventilation: 3% ivermectin vs 6% placebo; 50% improvement [95% CI, 0.24 –1.07].
  • Supplemental oxygen by non-invasive ventilation: 244 ivermectin vs 252 placebo; 78% vs 85%; 7% improvement [95% CI, 0.86–1.00].
  • Death: 13 ivermectin vs 18 placebo; 4% vs 6%; 33% improvement [95% CI, 0.35–1.39].

The fact that all these outcomes showed an improvement, and mechanical ventilation and death considerably so, is a signal that the benefit is unlikely to be solely due to chance. Thus the conclusion should really have been that a larger study is needed to see if the promising results can achieve statistical significance.

For outpatients, there were also some significant clinical benefits:

  • Fever duration: 2.02 (± 0.11) days ivermectin vs 2.41 (± 0.13) days placebo; 16% improvement.
  • On the day seventh of treatment, fever, cough and weakness were significantly higher in the placebo group compared to the ivermectin group.

A few results went the other way, though none of these were statistically significant. For inpatients:

  • Length of hospital stay: 7.98 (± 4.4) days ivermectin vs 7.16 (± 3.2) days placebo; 20% worse [95% CI, 0.15–1.45]. The study claims this finding is “significant”, but the wide confidence interval going through 1.0 indicates not. The authors write that “delays in discharging patients to other facilities such as rehabilitation centres… might be the reason for more extended hospital stay other than treatment for COVID-19”.
  • Mean oxygen saturation at day seven: 92.01 (Range: 72–99) ivermectin vs 93 (Range: 48–99) placebo; 1% worse [95% CI, –2.89 to 0.91].
  • Relative recovery (where some symptoms persist on discharge): 53% ivermectin vs 60% placebo; 13% worse [95% CI, 0.76–1.00].
  • Persistent dry cough (until seventh day): 5 ivermectin vs 10 placebo; 3% vs 9%; 36% worse [95% CI, 0.13–1.03].

For outpatients:

  • Hospitalisation: 7% ivermectin vs 5% placebo; 36% worse [95% CI, 0.65–2.84].
  • PCR negative on day five after treatment: 26% ivermectin vs 32% placebo; 19% worse [95% CI, 0.60–1.09].

The authors write that “no evidence was found to support the prescription of ivermectin on recovery, reduced hospitalisation and increased negative RT-PCR assay for SARS-CoV-2 five days after treatment in outpatients”. However, it’s important to note that this was for ivermectin given more than a week after symptoms began. Proponents of ivermectin often argue that treatment should be given within five days of exposure, i.e., as soon as possible.

The paper does mention this issue, though in a strange sentence with typographical errors perhaps indicative of a late addition: “Ivermectin may be going to be effective if it is given at the earliest possible time that clinical symptoms appear whiles [sic] the mean duration of symptoms before randomisation was 7.36 ± 3.43 days in the ivermectin group and 6.98 ± 3.63 days in the placebo group.” Typographical errors aside, the point is correct; an outpatient study really needs to start the treatment sooner.

There may also be a dosage issue. While the trial gave a dose of 0.4 mg per kg per day over a duration of three days, some have suggested a higher dose is required. The paper nods at this where it says: “Krolewiecki et al. assessed antiviral activity and safety of a five-day regimen of high dose ivermectin, comparing the control group in 45 patients with COVID-19. The findings support the hypothesis that ivermectin has a concentration-dependent antiviral activity against SARS-CoV-2.”

A further potential problem with the study, which was conducted in Iran where ivermectin has been popular as a Covid treatment, is the question of how many of the placebo group were also secretly taking ivermectin anyway. In the limitations the authors note that “after the allocation of ivermectin or placebo, a significant number of patients declined to be participants”, which may be because they realised they wanted to be sure they were taking the drug. Taking an antiviral medication was an exclusion criterion for outpatients – 18 admitted to it, but how many continued with the trial (for which they were presumably paid) but took such drugs anyway? Furthermore, previously taking an antiviral does not appear to have been an exclusion criterion for inpatients, so it is unknown how many placebo-arm inpatients had taken ivermectin or another medication prior to hospitalisation. Once in hospital, I imagine they would not have been able to continue taking any medication secretly, and perhaps that explains why nearly a third of the inpatient participants were lost to follow up, most due to voluntary withdrawal or “incomplete intervention” (31.6%, 282 of 891; 136 ivermectin and 146 placebo).

Overall, I find the conclusion baffling given the findings. There were statistically significant benefits of ivermectin for complete recovery, shorter duration of fever and quicker clearing up of cough and weakness. There were also large but not-statistically-significant benefits for mechanical ventilation and death. The negative findings were mostly small and none were statistically significant. This is for a study which didn’t start the treatment until over a week into symptoms, and may have been confounded by people in the placebo arm also taking the drug.

Perhaps we will never get to the bottom of exactly how effective ivermectin is against COVID-19. But since it’s a safe drug (to quote U.K. Chief Medical Officer Chris Whitty, “Ivermectin has proven to be safe. Doses up to 10 times the approved limit are well tolerated by healthy volunteers”) and this study shows once again that it gives some benefit – other studies show much greater benefit – why not be honest about that, allow medics to include it in their treatment protocol, and stop making such a fuss about stopping them?

June 23, 2022 Posted by | Deception, Science and Pseudo-Science | , | Leave a comment

Doctors Sue FDA, Allege Crusade Against Ivermectin ‘Unlawfully Interfered’ With Their Ability to Treat Patients

The Defender | June 6, 2022

Three physicians are suing the U.S. Food and Drug Administration (FDA) for launching what they allege is a “crusade” against ivermectin as a treatment for COVID-19 that “unlawfully interfered” with the doctors’ ability to practice medicine.

In a lawsuit filed June 2, Drs. Robert L. Apter, Mary Talley Bowden and Paul E. Marik argued the FDA acted outside of its authority by directing the public, including health professionals and patients, to not use ivermectin — even though the drug is fully approved by the FDA for human use.

The suit, filed in the U.S. District Court, Southern District of Texas, Galveston Division, also names the U.S. Department of Health and Human Services (HHS), HHS Secretary Xavier Becerra and Robert Califf, acting FDA commissioner.

According to the complaint:

“The FDA generally cannot ban particular uses of human drugs once they are otherwise approved and admitted to the market, even if such use differs from the labeling — commonly referred to as ‘off-label’ use.

“The FDA also can not advise whether a patient should take an approved drug for a particular purpose. Those decisions fall within the scope of the doctor-patient relationship.

“Attempts by the FDA to influence or intervene in the doctor-patient relationship amount to interference with the practice of medicine, the regulation of which is — and always has been — reserved to states.”

The plaintiffs said their lawsuit isn’t about whether ivermectin is an effective treatment for COVID-19. It’s about who determines the appropriate treatment for each unique patient and whether the FDA can interfere with that process.

In their complaint, they site an FDA publication, “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19,” and tweets from the FDA — including one implying that ivermectin is intended only for animals — among examples of the FDA discouraging the use of ivermectin.

The plaintiffs also argued if the FDA is allowed to interfere with the practice of medicine now, using the pandemic as a cover, “this interference will metastasize to other circumstances, destroying the carefully constructed statutory wall between federal and state regulatory powers, and between the FDA and the professional judgment of health professionals.”

“This lawsuit, brought by three eminently qualified physicians, is a welcome development,” said Mary Holland, Children’s Health Defense president and general counsel.

Holland told The Defender :

“These doctors rightfully assert that the FDA, assisted by corporate media, have unlawfully interfered in the doctor-patient relationship and the appropriate treatment for individual patients. Regulating the doctor-patient relationship is an area of well-established state, not federal, law.

“I hope these plaintiffs will enjoin the FDA from continuing to restrict access to ivermectin and from penalizing healthcare practitioners who use this licensed drug for their patients.”

The plaintiffs: well-respected in their field, high success rate treating COVID patients

Apter, who is licensed to practice medicine in Arizona and Washington and has a COVID-19 patient survival rate of more than 99.98%, was referred to the Washington Medical Commission and Arizona Medical Board for disciplinary proceedings for prescribing ivermectin to treat COVID-19.

In a press release, Apter said, “If doctors are freed to treat patients according to their best judgment and unprejudiced evaluation of the medical literature, many thousands more deaths and serious disabilities will be averted.”

Apter said the FDA’s pronouncements against the use of ivermectin “have been the basis for disciplinary actions against doctors, interfere with the doctor-patient relationship, and have had a severe chilling effect on the use of life-saving medication for a deadly disease.”

In the lawsuit, Apter argued that government pressure, “largely through the FDA,” also led pharmacies — especially in large corporate chains — to refuse to fill ivermectin prescriptions for COVID-19, because that position is supported by the FDA.

Bowden, who according to the lawsuit has 40 years of experience in emergency medicine, began recommending ivermectin to treat COVID-19 in early 2020. She treated more than 3,900 patients for COVID-19, with a success rate of over 99.97%.

She said the FDA’s actions regarding ivermectin, specifically its directives to stop using the drug to treat COVID-19, harmed Bowden’s ability to practice medicine and treat patients.

Bowden’s employer, Houston Methodist Hospital, last year forced her to resign by suspending her privileges for spreading “COVID misinformation.”

Bowden said she is “fighting back — the public needs to understand what the FDA has done is illegal, and I hope this suit will prevent them from continuing to interfere in the doctor-patient relationship.”

In an interview earlier this year with The Defender, Bowden said she was all for the COVID vaccines when they first came out — it was only when she started seeing what was happening with all the breakthrough cases that she wondered, “Why am I seeing so many COVID cases among the fully vaccinated?”

Then her patients began having adverse reactions. “If I hadn’t seen that firsthand, I would still think the vaccine was the way to go,” she said.

As the pandemic evolved, Bowden developed protocols for preventing and treating COVID patients. She said she’s seen excellent results.

“The basis of it is ivermectin,” she said. “And also vitamins C and D, quercetin and zinc, and black seed oil. It’s nothing complicated — and it’s just like with anything in medicine — not one size fits all — protocols are guidelines.”

The controversy over prescribing ivermectin was initially “intimidating and isolating,” she said. “I thought I was a little bitty island in a huge ocean, and now I realize that I’m part of at least half a continent.”

Marik, author of more than 750 publications, was professor of medicine and chief of pulmonary and critical care medicine at Eastern Virginia Medical School (EVMS) in Norfolk, Virginia, from 2009 through 2021. He also served as a director of the intensive care unit at Sentara Norfolk General Hospital.

He developed a protocol for EVMS for treating COVID-19, called the EVMS COVID-19 Management Protocol, which included the MATH+ Protocol.

However, according to the lawsuit, Marik was forced to resign from his positions at EVMS and Sentara Norfolk General Hospital for promoting the use of ivermectin — “as well as other safe, cheap, and effective off-label FDA-approved drugs” — to treat COVID-19 following the FDA’s attempts to stop use of those drugs for that purpose.

Marik alleged in the lawsuit that refusing to allow patients to receive effective early treatment for COVID-19 “led to innumerable hospitalizations and deaths, and caused extreme distress for patients, their families, and health professionals.”

Boyden, Gray & Associates, a Washington, DC-based law firm, is representing the plaintiffs.

Ivermectin was developed in the 1970s as a veterinary medicine to treat parasitic diseases in livestock, but a decade or so later was hailed as a “wonder drug” and received approval for human use as a therapeutic against diseases such as river blindness — or onchocerciasis — and lymphatic filariasis, according to Newsmax.

Since 1987, it has been used safely in 3.7 billion doses worldwide. William Campbell and Satoshi Omura won the 2015 Nobel Prize in Physiology or Medicine for their research on the drug.

Studies show ivermectin is associated with lower COVID-19 death rates, but the FDA — with help from mainstream media — continues to state the drug is ineffective for treating COVID.

© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

June 8, 2022 Posted by | Science and Pseudo-Science | , , , , | 3 Comments

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic 

By Toby Rogers | Thinking Points | April 4, 2022

Ivermectin is safer than aspirin and effective against Covid if used at the right dose prophylactically or in early treatment. It’s such an enormous breakthrough that the guy who discovered it (it’s a microbe in the soil) won the Nobel Prize for Medicine in 2015.

The FDA does not like ivermectin because it works and this costs the pharmaceutical industry hundreds of billions of dollars in lost vaccine profits. Almost everyone who works at FDA is auditioning for a job with a big pharmaceutical company. So the FDA ran and continues to run hit pieces against this Nobel Prize winning treatment, calling it “horse medicine.”

Of course many (most?) medicines have dual use in human and other animals — including antibiotics, pain relievers, chemotherapy drugs etc. So the FDA staff debased and degraded themselves in service of the cartel and now no one trusts them.

Well, to add insult to mass murder, it turns out that the whole time that the FDA was incorrectly calling ivermectin “horse medicine” it was developing with Merck, an actual horse medicine to treat Covid:

Molnupiravir began as a possible therapy for Venezuelan equine encephalitis virus at Emory University’s non-profit company DRIVE (Drug Innovation Ventures at Emory) in Atlanta. But in 2015, DRIVE’s chief executive George Painter offered it to a collaborator, virologist Mark Denison at Vanderbilt University in Nashville, Tennessee, to test against coronaviruses. “I was pretty blown away by it,” Denison remembers. He found that it worked against multiple coronaviruses: MERS and mouse hepatitis virus.

But here’s the kicker — molnupiravir is a mutagen — it changes DNA which will accelerate the creation of new variants and thus prolong the pandemic. It costs $700 per full course of treatment. Of course the FDA granted an emergency use authorization.

So to recap:

Safe and effective treatment for Covid, costs pennies, won the Nobel Prize for Medicine = ridiculed by FDA.

Actual horse medicine (TO TREAT AN ACTUAL HORSE VIRUS) that costs a fortune, changes your DNA, and prolongs the pandemic = praised by the FDA.

Arrest all of the FDA leadership and dismantle that building brick by brick.

April 4, 2022 Posted by | Corruption, Deception, Science and Pseudo-Science, Timeless or most popular, War Crimes | , , , | 3 Comments

NY Times Latest to Mislead Public on New Ivermectin Study

The NEJM study chose a much lower dose, 400mcg per day for only three days, less than half the total dose that has been shown to be effective

By Madhava Setty, M.D. | The Defender | March 31, 2022

The New York Times on Wednesday sent an email blast to subscribers with the subject line: “Breaking News: Ivermectin failed as a Covid treatment, a large clinical trial found.”

The Times was referring to a study I wrote about, that same day, for The Defender.

My article called out the Wall Street Journal for its March 18 reporting on the same study — before the study was even published — for its failure to provide an accurate, critical assessment of the study.

The study in question — “Effect of Early Treatment with Ivermectin among Patients with Covid-19” — was officially published Wednesday in the New England Journal of Medicine (NEJM).

In it the authors concluded:

“Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19”

The Times did not critique the study itself, but quoted the opinion of Dr. David Boulware, an infectious-disease expert at the University of Minnesota:

“There’s really no sign of any benefit. Now that people can dive into the details and the data, hopefully that will steer the majority of doctors away from ivermectin towards other therapies.”

Yes. Let us dive into the details and the data and see where it “steers” us, shall we?

A closer look at the details

The NEJM study took place in Brazil between March 23 and Aug. 6, 2021.

The study examined 1,358 people who expressed symptoms of COVID-19 at an outpatient care facility (within seven days of symptom onset), had a positive rapid test for the disease and had at least one of these risk factors for severe disease:

  • Age over 50
  • Hypertension requiring medical therapy
  • Diabetes mellitus
  • Cardiovascular disease
  • Lung disease
  • Smoking
  • Obesity
  • Organ transplantation
  • Chronic kidney disease (stage IV) or receipt of dialysis
  •  Immunosuppressive therapy (receipt of ≥10 mg of prednisone or equivalent daily)
  • Diagnosis of cancer within the previous 6 months
  • Receipt of chemotherapy for cancer.

Young and healthy individuals were not part of this study.

Both vaccinated and unvaccinated individuals were included in the study. The percentage of vaccinated participants in each group was not specified. Note that by choosing not to identify vaccination status as a confounding variable the authors are implying that vaccines are playing no role in preventing hospitalization.

The 1,358 subjects were divided into two equally sized groups that were relatively well-matched and randomized to receive either a three-day dose of placebo or a three-day course of ivermectin at 400 mcg/kg.

The primary outcome was hospitalization due to COVID-19 within 28 days after randomization or an emergency department visit due to clinical worsening of COVID-19 (defined as the participant remaining under observation for >6 hours) within 28 days after randomization.

How researchers were able to conclude ‘no benefit’ despite signs to the contrary

The study’s authors wrote:

“100 patients (14.7%) in the ivermectin group had a primary-outcome event (composite of hospitalization due to the progression of COVID-19 or an emergency department visit of >6 hours that was due to clinical worsening of COVID-19), as compared with 111 (16.3%) in the placebo group (relative risk, 0.90; 95% Bayesian credible interval, 0.70 to 1.16).”

In other words, a greater percentage of placebo recipients required hospitalization or observation in an emergency department than those who received Ivermectin.

The authors of the study broke it down by subgroups here:

As is demonstrated in nearly every subgroup, the Ivermectin recipients fared better than those who received the placebo.

However, these data were not statistically significant given the size of the study.

This is how the authors were able to conclude there was no benefit to ivermectin use in preventing hospitalization in high-risk patients in their study.

Patients were under-dosed, some didn’t follow instructions

As it stands, the study The New York Times and The Wall Street Journal declared as proof of the uselessness of ivermectin in treating COVID-19 is actually quite promising —  contrary to what their headlines told readers.

The dosing protocol advised by the Frontline COVID-19 Critical Care Alliance (FLCCC) includes a five-day course of ivermectin at 600 micrograms per kilogram of body weight for people with risk factors such as those possessed by participants in the study.

Instead, the investigators behind the NEJM study chose a much lower dose, 400mcg per day for only three days. This represents less than half of the total dose that has been shown to be effective in practice.

Furthermore, despite acknowledging that studies have shown some indication that the bioavailability of ivermectin increases when taken with food, especially a fatty meal, participants in the trial were instructed to take the medicine on an empty stomach.

In other words, the patients were significantly under-dosed — and yet a positive effect of the drug was emerging, though not statistically significant given the size of the study.

Also of note, the investigators chose to include emergency room visits with hospitalizations for COVID. Clearly, six hours of observation in an ER is a significantly different outcome than a hospitalization that may last a night or much longer.

When excluding the ER visits from the primary outcome and examining only hospitalizations, the ivermectin cohort had even less risk of an outcome, i.e. the relative risk was 0.84 vs 0.9 when ER visits and hospitalization were grouped together.

Perhaps the most glaring deficiency of the study is the low number of placebo recipients who actually followed the study’s protocol:

Only 288 of 679 participants randomized to receiving the placebo reported 100% adherence to the study protocol. Nearly 400 didn’t.

Why not? We asked Dr. Meryl Nass, an internist and member of the Children’s Health Defense scientific advisory committee.

Nass told The Defender :

“Presumably they knew the difference between ivermectin and placebo, and the placebo subjects went out and bought ivermectin or something else … but whatever they did, they didn’t bother with the pills they were given.

“So, it was not actually a double-blinded trial. Yet the 391 people who didn’t take the placebo but did something else were included in two of the three calculations of ivermectin efficacy anyway.”

So, was this the definitive answer proclaimed by mainstream sources? Nass thinks otherwise:

“I would say that instead, it was a failed trial due to the 391 placebo recipients who admitted they did not follow protocol versus the 55 in the ivermectin arm.”

More questions than answers

Rather than pounding the final nail in the coffin around ivermectin’s utility in treating COVID, the NEJM study raises more questions.

  • What would the effect have been if a higher dose shown to be effective were administered?
  • What would be the benefit of this medicine in patients with no risk factors?
  • How statistically significant would the results have been if more participants were enrolled?
  • Why weren’t more participants enrolled as the study progressed given the emerging benefit of the drug and the absence of adverse events?
  • Why did the investigators define a primary outcome with such different real-world implications (ER visits vs hospitalizations)?
  • With less than 50% of the placebo arm adhering to the study protocol, why were their outcomes included in the analysis?
  • What effect did vaccination status have on outcome? If this is the primary means endorsed to prevent hospitalization, why wasn’t vaccination status mentioned as a confounder?
  • Did the investigators choose to limit the study as it became clear that an Ivermectin benefit would be too big to ignore?

Given these obvious issues with the study, it is becoming even more clear where the real story is: Neither The Wall Street Journal or The New York Times are willing to pursue startling details around how corporate interests are corrupting scientific opinion as reported here.

Instead, these iconic journals chose to report on a scientific study on or prior to the day of publication using misleading headlines backed up by flimsy investigations conducted by journalists with no capacity to dissect the analysis or data.

Here’s a bigger question: Are they incompetent, or complicit, too?

© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

April 1, 2022 Posted by | Fake News, Mainstream Media, Warmongering, Science and Pseudo-Science | , , | Leave a comment


The Highwire with Del Bigtree | March 3, 2022

Del sits down for a one-on-one with the former W.H.O. consultant & research scientist, Tess Lawrie MD, PhD, who was a critical part of the Ivermectin trials over a year ago with overwhelmingly positive conclusions. See data and recorded personal zoom calls that reveal how a key review was attacked from within, keeping the safe, life-saving drug out of the hands of millions of dying Covid patients for more than a year.

March 9, 2022 Posted by | Corruption, Science and Pseudo-Science, Timeless or most popular, Video, War Crimes | , , , , , | 1 Comment


OracleFilms | March 4, 2022

In October 2020 Dr Andrew Hill was tasked to report to the World Health Organisation on the dozens of new studies from around the world suggesting that Ivermectin could be a remarkably safe and effective treatment for COVID-19.

But on January 18th 2021, Dr Hill published his findings on a pre-print server. His methods lacked rigour, the review was low quality and the extremely positive findings on ivermectin were contradicted by the conclusion. In the end, Dr Hill advised that “Ivermectin should be validated in larger appropriately controlled randomized trials before the results are sufficient for review by regulatory authorities.”

The researcher seeking a global recommendation on Ivermectin had instead recommended against it. A media onslaught against the medicine ensued. What were Dr Hill’s reasons for doing so? Were his conclusions justified? Or were external forces influencing his about-face?

One year on, this film recalls exactly what happened from the perspective of somebody that experienced it first hand; Dr Tess Lawrie; also featuring contributions from Dr Pierre Kory and Dr Paul Marik who worked closely with Dr Hill during the same time frame.

⁣If you like what Oracle Films does, you can support us here: ⁣

Follow us on Telegram:

Dr. Tess Lawrie interview with Del Bigtree of The Highwire (Mar 3, 2022)

March 5, 2022 Posted by | Science and Pseudo-Science, Timeless or most popular, Video, War Crimes | , , , | Leave a comment

You can’t claim vaccine is the only Covid life saver when treatments are banned!

By Kathy Gyngell | TCW Defending Freedom | February 23, 2022

EACH week, members of the UK’s watchdog Medicines and Healthcare products Regulatory Agency publish their Yellow Card update on adverse reactions to the Covid vaccine.

Every time they do so, they repeat this claim: ‘Vaccination is the single most effective way to reduce deaths and severe illness from Covid-19.’

But how do they know?

The fact is as long as treatments such hydroxychloroquine and ivermectin continue to be banned in the UK, we are prevented from knowing whether treatment could be more effective than vaccines in preventing deaths and reducing severe illness. Published research indicates it could be.

Furthermore without a proper investigation into the thousands of hospital Covid fatalities, how can we know whether the chosen treatment protocols have not been as responsible a cause of death as the disease itself?

In the US, the National Institutes of Health treatment protocol guidance for Covid is based on two drugs, dexamethasone and remdesivir. 

Yet at least one major study has called remdesivir into question. Published almost exactly a year ago, it found kidney disorders to be a serious adverse reaction of the drug in coronavirus disease.

It reported that compared with the use of chloroquine, dexamethasone, sarilumab, or tocilizumab, the use of remdesivir was associated with an increased reporting of kidney disorders.

The research states that ‘in the vast majority of cases (316 – 96.6 per cent), no other drug was suspected in the onset of kidney disorders. Reactions were serious in 301 cases (92 per cent) cases, with a fatal outcome for 15 patients (4.6 per cent).

The NHS  ‘guidance pathways’ for severe Covid cases – which cover respiratory support to end of life support – are set out here. Other guidance states that ‘treatment with remdesivir may be considered in certain hospitalised patients with Covid‑19 pneumonia’.

Clinicians can also ‘offer dexamethasone to patients with Covid‑19 who need supplemental oxygen, or who have a level of hypoxia (lack of oxygen) that requires supplemental oxygen but are unable to have or tolerate it. If dexamethasone is unsuitable or unavailable, either hydrocortisone or prednisolone can be used.’

An Oxford Recovery Trial for hospitalised Covid patients found ‘the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomisation but not among those receiving no respiratory support.’

The perceived limitations of the data are set out here. But for all the glowing testimonials, the survival of the patients in the trial groups – a 22.9 per cent death rate – was not a huge improvement on that in the usual care group, 25.7 per cent

‘Overall, 482 patients (22.9 per cent) in the dexamethasone group and 1,110 patients (25.7 per cent) in the usual care group died within 28 days after randomisation (age-adjusted rate ratio, 0.83; 95 per cent confidence interval [CI], 0.75 to 0.93; P<0.001).’

What this drug treatment was not compared with was the efficacy of either hydroxychloroquine or ivermectin, two successful early intervention treatments that perversely remain banned here.

Sadly we will never know how many lives would have been saved had these drugs been introduced into community and hospital protocols a year ago? I rest my case.

Isn’t it high time the MHRA revised its claim to say: ‘Vaccine is the single most effective way to reduce deaths and severe illness from Covid-19 in the absence of potentially effective treatments which are banned in the UK.’

Below is the latest full Yellow Card adverse reaction breakdown. It follows a week marked by another seven deaths and a further 82 adverse reactions reported for children, all of which continue to go unremarked by the mainstream media.

MHRA Yellow Card reporting summary up to February 9, 2022 (Data published  February 17, 2022)

Adult – primary and booster/third dose, child administration. 

* Pfizer: 25.9million people, 49million doses. Yellow Card reporting rate, one in 157 people impacted.

* Astrazeneca: 24.9million people, 49.1million doses. Yellow Card reporting rate, one in 102 people impacted.

* Moderna: 1.6million people, three million doses. Yellow Card reporting rate, one in 45 people impacted.

Overall, one in 118 people injected experienced a Yellow Card adverse event, which may be less than ten per cent of actual figures, according to the MHRA.

The MHRA states that:

* Vaccination is the single most effective way to reduce deaths and severe illness from Covid-19.

* The expected benefits of the vaccines in preventing Covid-19 and serious complications associated with Covid-19 far outweigh any currently known side-effects in the majority of patients.

Adult booster or third doses given = 37,650,239.

Booster Yellow Card reports: 28,941 (Pfizer) + 466 (AZ) + 15,870 (Moderna) + 151 (Unknown) = 45,428.

Reactions: 472,956 (Pfizer) + 862,394 (AZ) + 118,425 (Moderna) + 4653 (Unknown) = 1,458,428.

Reports: 164,679 (Pfizer) + 243,491 (AZ) + 35,566 (Moderna) + 1520 (Unknown) = 445,256 people impacted.

Fatal718 (Pfizer) + 1,221 (AZ) + 38 (Moderna) + 40 (Unknown) = 2,017.

Blood disorders: 16,759 (Pfizer) + 7793 (AZ) + 2428 (Moderna) + 62 (Unknown) = 27,042.

Anaphylaxis: 649 (Pfizer) + 871 (AZ) + 87 (Moderna) + 2 (Unknown) = 1,609.

Pulmonary embolism and deep vein thrombosis: 875 (Pfizer) + 3,029 (AZ) + 106 (Moderna) + 25 (Unknown) = 4,035.

Acute cardiac: 12,273 (Pfizer) + 11,147 (AZ) + 3,009 (Moderna) + 90 (Unknown) = 26,519.

Eye disorders: 7,772 (Pfizer) + 14,797 (AZ) + 1,460 (Moderna) + 83 (Unknown) = 24,112

Blindness: 155 (Pfizer) + 317 (AZ) + 31 (Moderna) + 4 (Unknown) = 507.

Deafness: 288 (Pfizer) + 424 (AZ) + 50 (Moderna) + 5 (Unknown) = 767.

Spontaneous abortions: 471 + 1 premature baby death / 15 stillbirth/foetal deaths (11 recorded as fatal) (Pfizer) + 229 + 5 stillbirth (AZ) + 60 + 1 stillbirth (Moderna) + 5 (Unknown) = 765 miscarriages

Nervous system disorders: 78,872 (Pfizer) + 182,030 (AZ) + 19,215 (Moderna) + 839 (Unknown) = 280,956.

Seizures: 1,068 (Pfizer) + 2,050 (AZ) + 250 (Moderna) + 17 (Unknown) = 3,385.

Paralysis: 495 (Pfizer) + 871 (AZ) + 98 (Moderna) + 8 (Unknown) = 1,472.

Tremor: 2,117 (Pfizer) + 9,925 (AZ) + 637 (Moderna) + 50 (Unknown) = 12,729.

Vertigo and tinnitus: 4,078 (Pfizer) + 6,897 (AZ) + 684 (Moderna) + 39 (Unknown) = 11,698

Transverse myelitis: 34 (Pfizer) + 116 (AZ) + 2 (Moderna) = 152

BCG scar reactivation: 67 (Pfizer) + 38 (AZ) + 51 (Moderna) = 156

Headaches and migraines: 35,041 (Pfizer) + 93,844 (AZ) + 9,112 (Moderna) + 331 (Unknown) = 138,328

Vomiting: 5,134 (Pfizer) + 11,631 (AZ) + 1,727 (Moderna) + 59 (Unknown) = 18,551

Infections: 11,611 (Pfizer) + 20,089 (AZ) + 2,160 (Moderna) + 150 (Unknown) = 34,010.

Herpes: 2,149 (Pfizer) + 2,676 (AZ) + 240 (Moderna) + 23 (Unknown) = 5,088.

Immune system disorders: 2,369 (Pfizer) + 3,274 (AZ) + 593 (Moderna) + 21 (Unknown) = 6,257.

Skin disorders: 33,094 (Pfizer) + 53,154 (AZ) + 12,637 (Moderna) + 330 (Unknown) = 99,215.

Respiratory disorders: 20,950 (Pfizer) + 29,585 (AZ) + 4,015 (Moderna) + 196 (Unknown) = 54,746.

Epistaxis (nosebleeds): 1,063 (Pfizer) + 2302 (AZ) + 188 (Moderna) + 11 (Unknown) = 3,564.

Psychiatric disorders: 9,876 (Pfizer) + 18,289 (AZ) + 2,339 (Moderna) + 108 (Unknown) = 30,612.

Reproductive/breast disorders: 30,236 (Pfizer) + 20,649 (AZ) + 4,905 (Moderna) + 199 (Unknown) = 55,989

Children and young people special report – suspected side-effects reported in under-18s:

* Pfizer: 3,200,000 children (first doses) plus 1,500,000 second doses, resulting in 3,044 Yellow Cards.

* AZ: 12,400 children (first doses) resulting in 254 Yellow Cards. Reporting rate one in 49.

* Moderna: 2,000 children (first doses) resulting in 18 Yellow Cards.

* Brand unspecified: 18 Yellow Cards.

Total = 3,214,400 children injected

Total Yellow Cards for under-18s = 3,334

The MHRA states that all children aged five to 11 will be eligible for vaccination in the coming weeks.

For full reports, including 347 pages of specific reaction listings, see here. 

February 23, 2022 Posted by | Deception, Science and Pseudo-Science, Timeless or most popular, War Crimes | , , , , , | Leave a comment

Oklahoma AG declares medical boards can’t punish doctor for prescribing ivermectin

LifeSiteNews | February 16, 2022

OKLAHOMA CITY – Doctors in Oklahoma are well within their professional rights to prescribe ivermectin (IVM) and hydroxychloroquine (HCQ) to COVID-19 patients, state ​​Attorney General John O’Connor affirmed, despite the drugs’ disfavored status within the federal health bureaucracy.

“The Attorney General’s office finds no legal basis for a state medical licensure board to discipline a licensed physician for exercising sound judgment and safely prescribing an FDA-approved drug – like ivermectin or hydroxychloroquine – for the off-label purpose of treating a patient with COVID-19,” O’Connor’s office concluded in a February 8 statement, declaring that “healthcare professionals should have every tool available to combat COVID-19.”

“The Attorney General’s office neither condones nor condemns a specific course of treatment for COVID-19,” the release added. “Our office maintains that proper healthcare decisions are to be made between a patient and his or her physician, and the government should not interfere with their relationship.”

Despite being misrepresented in the mainstream media as aquarium cleaner and horse dewormer, respectively, hydroxychloroquine and ivermectin are both FDA-approved medications with a range of human applications, such that both are listed on the World Health Organization’s Model List of Essential Medicines. Like many medications, ivermectin is also used for horses, but human dosages of the drug for human ailments were not controversial until IVM started gaining notice in the context of COVID-19.

While experts continue to debate the drugs’ effectiveness at treating COVID-19, promising studies as well as reports of positive results have generated significant interest in them, as has the fact that they have been used and studied for far longer than the COVID-19 vaccines, which were developed and released in record time by the Trump administration’s Operation Warp Speed initiative. Many believe the long-established drugs are safer than relatively new vaccines they believe have been rushed and politicized.

Despite the established safety of IVM and HCQ, and the evolving nature of COVID knowledge, families across the country have had to go to court to force hospitals to let them try the drugs for their loved ones, while doctors have seen their medical licenses threatened for prescribing them – a scenario the Oklahoma Attorney General’s Office indicates will not be tolerated in the Sooner State.

The University of Minnesota, Emory University School of Medicine, Northwestern Medicine, and other medical institutions are currently conducting a major at-home clinical trial to assess ivermectin’s effectiveness at treating COVID-19, as well as that of the drugs metformin and fluvoxamine or any combination of the three.

February 18, 2022 Posted by | Aletho News | , , , , | 2 Comments

The extraordinary story of how patient access to COVID treatments were denied

Eventually involving witch hunts of physicians who dared to treat patients

By Meryl Nass, MD | February 11, 2022

In 2020, I compiled a list of over 50 ways authorities and pharma companies in multiple countries stopped the use of the chloroquine drugs for COVID. This was (and is) a stunning collection,which has been widely read and reproduced on many websites. When you read it, you are astounded to learn that all the US (and many international) public health agencies took many different actions to increase deaths and destruction from COVID and prolong the pandemic. “Avoiding the Trump drug” served as a great cover story. Taking hydroxychloroquine for COVID was equated to drinking bleach.

But here’s the kicker: the authorities knew all about chloroquine and other treatments for COVID before there was a COVID… because they had figured it out for the 2002 SARS epidemic and the 2012 MERS epidemic, both caused by related coronaviruses.  But they hushed it up.

Five CDC (US government) scientists published a paper, along with three Canadian government scientists, showing that chloroquine was an effective drug against SARS coronaviruses, in 2005. European scientists had shown the same thing in 2004.

Here is the CDC paper:

and here is its conclusion:

It looked very promising for both prevention and treatment of the first SARS.  After all, it has been used for many decades both to prevent and to treat malaria. (I took it for prevention, and later for treatment, 50 years ago.)

Nine years later, In 2014, scientists in Tony Fauci’s NIAID showed the same thing. Not only did chloroquine work in vitro against the MERS coronavirus, but dozens of existing drugs, which could have been tested in patients as soon as the pandemic started, were also effective against SARS and MERS coronaviruses.

Here is the paper from Fauci’s NIAID:

And this is what the NIAID authors said:

Here we found that 66 of the screened drugs were effective at inhibiting either MERS-CoV or SARS-CoV infection in vitro and that 27 of these compounds were effective against both MERS-CoV and SARS-CoV. These data demonstrate the efficiency of screening approved or clinically developed drugs for identification of potential therapeutic options for emerging viral diseases and also provide an expedited approach for supporting off-label use of approved therapeutics.

Just in case you think these papers were flukes, two unrelated  groups of European scientists found essentially the same thing. The 2014 European paper was published back to back with the NIAID paper above. I have cited the 2004 European paper elsewhere, and these citations can also be found in Bobby Kennedy’s book The Real Tony Fauci, which according to Amazon has now sold over 800,000 copies. Please read it. OTOH, If you are seeking misinformation on COVID, I’d recommend Fauci’s own book, Expect the Unexpected.

I have to repeat myself, because the information is so shocking and I don’t want you to miss it: our governments already knew of options for treating COVID before it appeared, but instead of immediately trying these already identified, safe, cheap, and available repurposed drugs, and offering early treatments, they did everything they could to stop people obtaining the chloroquine drugs. Look up the articles I linked to above. Read my long article on this suppression. Or the two articles I wrote here and here about how patients were administered borderline lethal doses of hydroxyhcloroquine to give the drug a black eye. Check the links. Verify that what I have just written is correct. Human beings planned and carried out these medical crimes against humanity. Who are those humans? What are they doing now?

This has to be be investigated and justice attained, to prevent such crimes from happening to patients ever again.

The “Why?” and “How could this be?!!” requires people to take a huge leap in order to understand the world we live in. Many don’t have the fortitude to dissect their world view and rebuild it in accord with the facts that have spilled out over the last two years.

But I am about to present some more facts that I hope you can assimilate into your understanding of the world. It might require a stiff drink, or perhaps some chocolate. Whatever it takes, read on, as it might save your life or someone else’s.


Ivermectin had not been identified in the studies I mentioned above as a potentially useful coronavirus drug.

But some people knew it was likely to work in early 2020, because the French MedInCell company, supported by Bill Gates, was working on an injectable (which would make it patentable) version of ivermectin for COVID, issuing a press release about this on April 6, 2020 and an informational paper on April 23, 2020. There was a brief run on the veterinary drug at this time in the US, according to an FDA warning issued on April 10, 2020, indicating some people knew it might be an effective COVID treatment and were acquiring it. But there was not a lot of buzz and sales did not take off at that time.

Here is what FDA said on April 10, 2020:

FDA is concerned about the health of consumers who may self-medicate by taking ivermectin products intended for animals, thinking they can be a substitute for ivermectin intended for humans… Please help us protect public health by alerting FDA of anyone claiming to have a product to prevent or cure COVID-19 and to help safeguard human and animal health by reporting any of these products

In December 2020, a full eight months later, Ron Johnson held a Senate hearing that was focused on ivermectin’s benefits for COVID. Intensive care specialist Dr. Pierre Kory, originally a New Yorker, gave a particularly compelling speech. People began paying attention to the drug. YouTube then removed Kory’s speech–censoring a Senate hearing!

I think the authorities were initially scared to repeat the same tricks with ivermectin they had used to beat down the chloroquine drugs. And because ivermectin has efficacy late in the disease as well as at the start, and is not toxic at several times the normal dose, some of the tricks used against chloroquine (giving it too late in the disease course or overdosing patients) simply would not work with ivermectin. The authorities kept quiet.

But then ivermectin’s popularity started exploding. CDC published a report in late August showing that ivermectin prescriptions had quadrupled in a month, and the drug was now selling at 25 times the pre-COVID rate.


More than 88,000 prescriptions for the drug were filled by pharmacies in the week ending August 13, the CDC said in a report published August 26.” 

Apparently this terrified the powers-that-be. What if the pandemic got wiped out with ivermectin? It worked too well! Would that be the end of vaccine mandates, boosters, vaccine passports and digital IDs? The end of the Great Reset? Something had to be done, and fast. It had to be big. It had to be effective. They couldn’t simply take the drug off the market; that would require a long process and a paper trail.

What to do? There was probably only one option: Scare the pants off the doctors. Loss of license is the very worst thing you can do to a doctor. Threaten their licenses and they will immediately fall into line. You can’t get a prescription if there is no doctor to write it.

The method had been tested in the Philippines.

The powers-that-be could also scare the pharmacies. This required stealth. No paper trails. Intimidation was required, backed by a one-two punch: actually suspending doctors’  (annd maybe pharmacists’) licenses. You couple that with a huge media offensive, and threats from an industry of medical “non-profits.” You suddenly invent “misinformation” as a medical crime, studiously failing to define it. You make people think the legal prescribing of ivermectin and hydroxychloroquine is a crime, even though off-label prescribing is entirely legal under the federal Food, Drug and Cosmetic Act.

Did Fauci give the order? Walensky? Acting FDA Commissioner Woodcock? It was probably some combination, plus the public relations professionals managing the messaging and the media.

Here’s what happened.

1. Senator Ben Ray Lujan (D, NM) and several other Senators introduced the “Health Misinformation Act” in July 2021 because “misinformation was putting lives at risk,” he said. A huge supporter of COVID vaccinations, the 49 year old Senator suffered a stroke on February 1, 2022.

2. The pharmacies suddenly could not get ivermectin from their wholesalers. No reason was given except ‘supply and demand.’ But it seemed the supply was cut off everywhere.  Ivermectin was dribbled out by the wholesalers, a few pills a week per pharmacy, not enough to supply even one prescription weekly. Some powerful entity presumably ordered the wholesalers to make the drug (practically) unavailable. With no shortages announced. I called the main manufacturer in the US, Edenbridge, and was told they were producing plenty.

Hydroxychloroquine had been restricted in a variety of ways, determined by each state, since early 2020. It had also been restricted by certain manufacturers in 2020. Suddenly, in September 2021, it too became considerably harder than it already was to obtain.

3. In late August, CDC sent out a major warning about ivermectin, but only gave 2 examples of anyone having a problem with the drug: one person overdosed on an animal version and one overdosed on ivermectin bought on the internet. This should not have been news. However, pharmacists and doctors read between the lines and knew this was code for “verboten.” Almost all stopped dispensing ivermectin at that time. It should be of interest to everyone that our health agencies now speak in coded messages to doctors and pharmacies, presumably to avoid putting their threats on paper and being accountable for them. What a way for government to do business.

4. Also last August, various “nonprofit” medical organizations started issuing warnings, in concert, regarding doctors prescribing ivermectin or hydroxychloroquine, and spreading misinformation, especially about COVID vaccines. These organizations included the Federation of State Medical Boards, the American Medical Association, the American Pharmacy Association, and several specialty Boards. Here is an example of the AMA’s language:

“A handful of doctors spreading disinformation have fostered belief in scientifically unvalidated and potentially dangerous “cures” for COVID-19 while increasing vaccine hesitancy…”

These organizations told doctors they could lose their licenses or board certifications for such “crimes.” Mind you, none of these so-called nonprofit organizations has any regulatory authority. Nor do I believe they have any authority to claw back a Board Certification. They were blowing smoke. And they were probably paid to do so. Who paid?

5. Over the course of 3 days at the end of August, national media reported on 4 doctors in 3 states whose Boards were investigating them for the use of ivermectin.

Hawaii’s Medical Board went after Hawaii’s chief medical officer:

The Hawaii Medical Board has filed complaints against Maui’s top health official and a Valley Isle physician following reports that they backed COVID-19 treatments that state and federal health agencies advise against.

They really wanted to make an example by going after the state’s chief medical officer, who had had the guts to treat COVID patients. Clearly the orders are coming from high up on the food chain.

Here were some of the other August headlines about doctors who legally prescribed a fully approved drug off-label:

6. The Federation of State Medical Boards (FSMB) is an organization that assists 71 state and territorial medical boards with policies, training, etc. Members pay dues and the organization accepts donations. It has its own foundation, too. Its President earns close to $1,000,000/year, not bad for a backwater administrative job at an organization headquartered in Euless, Texas. After the FSMB instructed its members that misinformation was a crime, somewhere between 8 and 15 of its member boards began to take action.  (Media have reported that 8, 12 or 15 boards of its 71 member Boards did so, according to the FSMB, which is closely monitoring this.)

7. On February 7, 2022 the Department of Homeland Security issued its own dire warning about the spread of misinformation, disinformation and a neologism, malinformation.

“The United States remains in a heightened threat environment fueled by several factors, including an online environment filled with false or misleading narratives and conspiracy theories, and other forms of mis- dis- and mal-information (MDM) introduced and/or amplified by foreign and domestic threat actors. These threat actors seek to exacerbate societal friction to sow discord and undermine public trust in government institutions to encourage unrest, which could potentially inspire acts of violence. Mass casualty attacks and other acts of targeted violence conducted by lone offenders and small groups acting in furtherance of ideological beliefs and/or personal grievances pose an ongoing threat to the nation.

Thus it appears that Misinformation and Disinformation have been selected to play an important role in a newly developing narrative, as the Pandemic restrictions and narrative come to an end.

8. I presume the majority of the 71 Medical Boards’ attorneys knew something about the Constitution, knew that every American has an inalienable right to freedom of speech, and simply ignored the FSMB’s exhortation to go after misinformatin spreaders. The Maine Board, however, went along. Three doctors in Maine have recently had their licenses suspended or threatened for writing waivers for COVID vaccines, spreading misinformation, and/or prescribing ivermectin and hydroxychloroquine. (All three of which are legal activities for doctors.). But Boards have broad powers to intervene, and are shielded from liability as agents of the state. So they went after a chronic Lyme doctor several years ago, who found, as expected, that it would be too onerous to fight back, and he gave up his license.

9. Here is what the Board claims about me:

“The board noted that Ivermectin isn’t Food and Drug Administration “authorized or approved” as a treatment for COVID-19 in the suspension order.”

“The board said that her continuing to practice as a physician “constitutes an immediate jeopardy to the health and physical safety of the public who might receive her medical services, and that it is necessary to immediately suspend her ability to practice medicine in order to adequately respond to this risk.”’

I am 70 years old, and my medical practice was set up as a service, so that everyone could access COVID drugs who wanted them. My fee was $60 per patient for all the COVID care they needed.

I am sure the Board had calculated that given all the above, I would not challenge the Board’s suspension and would simply surrender my license, since it would probably cost hundreds of thousands of dollars to fight the Board’s actions in court.

On the day my license was suspended, there was massive national publicity about my case. The story was on the AP wire, covered from the San Francisco Chronicle to the Miami Herald. And for some reason, it was not behind the usual paywall. The Hill, Newsweek, the Daily Beast and many other publications all ran hit pieces about me.

I realized that my situation was bigger than just a Maine issue: it had been selected to serve as an example to physicians nationwide who might be thinking for themselves and prescribing early treatment for COVID. Once I realized I was to be made an example of, as part of a national purge of doctors who think independently, I decided to fight back. Fortunately, Children’s Health Defense is helping with my legal expenses, which is what allows me to mount a strong attack against the bulldozing of free speech, patient autonomy and the doctor-patient relationship. Please join me in the fight!

February 11, 2022 Posted by | Book Review | , , | 1 Comment

More Important Ivermectin Study Results

Click here for more details on the map above
By Robert W Malone MD, MS | February 6, 2022

Strictly regular use of ivermectin as prophylaxis for COVID-19 leads to a 90% reduction in COVID-19 mortality rate, in a dose-response manner: definitive results of a prospective observational study of a strictly controlled 223,128 population from a city-wide program in Southern Brazil

Research Gate, February 2022 DOI:10.13140/RG.2.2.20069.68320

This important preprint needs to hit alternative and mainstream media now.

The Study:

Background: Previously, we demonstrated that ivermectin use as prophylaxis for COVID-19 was associated with reductions in COVID-19 infection, hospitalization, and mortality rates, and in the risk of dying from COVID-19, irrespective of regularity and accumulated use of ivermectin, in an observational, prospectively obtained data from a strictly controlled city-wide program in a city in Southern Brazil (Itajaí, SC, Brazil) of of medically-based, optional use of ivermectin as prophylaxis for COVID-19.

In this study, our objective was to explore the data obtained from the program to evaluate whether the level of regularity of ivermectin use impacted in the reductions in these outcomes, aiming to determine if ivermectin showed a progressive dose-, regularity-response in terms of protection from COVID-19 and COVID-19 related outcomes.

Materials and methods: This is a prospective observational study of the program mention above, that used ivermectin at a dose of 0.2mg/kg/day for two consecutive days, every 15 days. We obtained and analyzed the data regarding the accumulated dose of ivermectin use, in addition to age and co-morbidities, to analyze the patterns of reduction of COVID-19 infection, hospitalization, and mortality rates, and risk of dying from COVID-19, according to the regularity and amount of ivermectin used in a 5-month period.

Following definitions of regularity, we considered as strictly regular subjects that used at least 180mg of ivermectin (180mg = 30 tablets), and as sporadic users subjects that used 60mg (= 10 tablets) or less during the 5-month period.

Comparisons between subjects that did not use ivermectin and these two levels of regularity of ivermectin use were performed. Analysis of the intermediate levels of ivermectin use are present in the supplement appendix of this study. To analyze hospitalization and mortality rates, we utilized the database of COVID-19 infections of all participants, from Itajaí and outside. To analyze COVID-19 infection rate and risk of dying from COVID-19 we utilized the Itajaí city database.

Propensity score matching (PSM) was employed, followed by multivariate adjusted analysis for residual differences (doubly adjusted analysis).


  • Of the 7,345 cases of COVID-19, 3,034 occurred in non-users, 1,627 in sporadic users, and 289 in strict users, while the remaining cases occurred in the intermediate levels of ivermectin use. Strict users were older (p < 0.0001) and non-significant higher prevalence of type 2 diabetes and hypertension.
  • COVID-19 infection rate was 39% lower among strict users [4.03% infection rate; ( p < 0.0001] than in non-users (6.64% infection rate), and non-significant 11% reduction compared to sporadic users (4.54% infection rate) (n = 1,627 in each group; RR, 0.89; 95%CI 0.76 – 1.03; p = 0.11).
  • Hospitalization rate was reduced by 100% in strict users, compared to non-users and to sporadic users, both before and after Propensity score matching ( p < 0.0001).
  • After Propensity score matching, hospitalization rate was 35% lower among sporadic users than non-users (RR, 0.65; 95%CI, 0.44 – 0.70; p = 0.03).
  • In propensity score matched groups, multivariate-adjusted mortality rate was 90% lower in strict users compared to non-users (p = 0.003) and 79% lower than in sporadic users (p = 0.05), while sporadic users had a 37% reduction in mortality rate compared to non-users (p = 0.043).
  • Risk of dying from COVID-19 was 86% lower among strict users than non-users (p = 0.006) and marginally significant, 72% lower than sporadic users (p = 0.083), while sporadic users had a 51% reduction compared to non-users (p = 0.001).

Conclusion: Non-use of ivermectin was associated with a 10-times increase in mortality risk and 7-times increased risk of dying from COVID-19, compared to strictly regular use of ivermectin in a prospectively collected, strictly controlled population.

A progressive dose-response pattern was observed between level of ivermectin use and level of protection from COVID-19 related outcomes and consistent across different levels of ivermectin use.

The results of this study clearly demonstrate that prophylactic use of ivermectin must be initiated immediately for people in high risk categories in the United States and worldwide. This includes individuals with one or more co-morbidities and the middle aged/elderly. Our “design-to-fail” government funded clinical trials for early treatment and governmental obstructionism regarding life saving treatments to patients must end now.

The CDC chart below for all deaths since the start of the outbreak clearly shows a jump in deaths after 50 years old.

However, as the data for deaths per million per age group is not disclosed, so the age for start of prophylaxis has yet to be determined.

As Omicron has less pathogenicity and slightly different disease profile this too could influence what age prophylaxis treatment should begin. But the data are in, prophylactic use of ivermectin saves lives.

In regards to the table above, the age stratification of disease shows why a universal vaccination program for a vaccine with a high adverse event profile is not advised. It is time to stop all mandates at the Federal and State level. It is time to stop pushing this vaccine on children.

Research and clinical practice show that using re-purposed drugs for Covid-19 have huge benefits. These include multi-drug, multi-staged treatments for Covid-19 disease that prevent severe disease, decreases hospitalization rates and decreases death. It is time our government and state licensing board recognize this and let physicians practice medicine.

‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use. Int J Impot Res. 2008 Mar-Apr;20(2):135-44. doi: 10.1038/sj.ijir.3901619. Epub 2007 Nov 15. PMID: 18004389.


  • A doctor’s decision to inform the patient of the ‘off-label’ status of the prescription is not relevant to the physician’s standard of care for an informed consent case.
  • The FDA has specifically stated that its procedures and requirements have no effect on the practice of medicine and that the FDA does not prohibit doctors from prescribing drugs in an ‘off-label’ manner.
  • The FDA’s approval of a drug is immaterial to the effectiveness in the drug’s ‘off-label’ use. In fact, prescribing medication in an ‘off-label’ manner can constitute the standard of care in many cases.
  • A doctor’s duty is to practice medicine and treat his patient, not inform the patient of the FDA’s non-medically related labeling. Therefore, doctors should not be branded with the additional duty of disclosing non-pertinent information, such as the FDA’s medically irrelevant distinction, to their patients

*It is estimated that 21% of all prescription drugs are prescribed “off-label.”

For fun, I took the countries that reportedly use Ivermectin country-wide and compared them to the USA, Israel and Sweden. I chose a three month cut-off, although the results were extended further. I did this because I don’t know when some of the countries began ivermectin use.

Can you guess who now has the highest death rates per million? Yeh –

  1. USA
  2. Israel
  3. Sweden

Notes: I included – India, because although not all regions use Ivermectin – although the most populated due. Likewise Africa – which many nations treat with ivermectin prophylactically and these world maps do not break down Africa by Nations (weirdly imperialistic). I did not include Bulgaria, as although they use ivermectin – their death rate numbers are skewed for other reasons not worth delving into.

There are a lot of confounding variables here. Such as natural immunity, vaccination rates of the elderly and those with co-morbidities, as well as seasonality of the virus, vitamin D3/zinc levels and age of population.

But it is still an interesting snap shot as to where much of the world is right now.

February 6, 2022 Posted by | Science and Pseudo-Science, Timeless or most popular | , , | 1 Comment

The Global Disinformation Campaign Against Ivermectin in COVID-19 (Part I)

By Pierre Kory | January 6, 2022

Ivermectin, a decades-old, off-patent drug costing pennies to make, with an unparalleled safety profile and numerous manufacturers across the world, actually sits atop one of the largest and strongest clinical trials evidence base in history. The existing, massive amount of clinical trials data shows immense efficacy against COVID-19 in all its phases; prevention, early and late treatment, and long-haul syndrome (no actual trials in long-haul but rather extensive positive clinical experiences). Despite this inarguable (yes, inarguable) supportive evidence, no major Western or international health agency has recommended its use in COVID-19. Conversely, ivermectin has been officially adopted for early treatment in all or part of 23 “less developed” countries (39 if you include non-government medical organizations), and which include about 25% of the world’s population.

Now, before we delve deeper into the workings of the most heinous disinformation campaign ever waged by the pharmaceutical industry in history (and also it’s most successful so far as 75% of the earth’s inhabitants still have not been recommended to use it to treat COVID), I will ask you not to just “take my word for it” but instead take you on a brief, guided tour of the insanely positive evidence base supporting the use of ivermectin in COVID-19.

Let’s go. First, the below “Forest Plot” was compiled by the anonymous expert research group at (not enough can be said of the impact their meticulous work has had on COVID clinicians and scientists across the globe). Please visit their site, it is mind-blowingly impressive. The compounds listed in the rows represent the medicines with the most clinical trials evidence as of today, either by size or by number and are listed in order of potency against COVID.

Here is how to read and understand a Forest Plot: there is a thin grey line in the center, on either side of which are plotted squares which represent an estimate of the true size of the “treatment effect,” derived from an average of the treatment effects measured from all the trials performed of that medicine. If the box is squarely on the vertical line it means it is a treatment whose benefits have been found equal to its harms. In the above list, (with the exception of one) medicines with “positive” treatment effects are listed, meaning the benefits of treatment with these agents outweigh any potential or actual harms. No medicine on the list above, besides convalescent plasma (CP), indicates it is inferior to placebo (note that CP was the initial favored therapy of every single academic medical center in the U.S despite the fact CP has only ever been shown to be effective in hematogenous infections). In cases, such as with CP, due to the fact it’s harms outweigh it’s benefits, the box is plotted on the right side of the line and shaded in red. Conversely, the farther to the left of the vertical line that a box is plotted, the larger the measured impact on the clinical outcome tested. Green boxes indicate the effect estimate is based on at least 4 trials. Grey boxes and greyed out medicine names mean the estimate for that medicine is based on fewer than 4 trials. The thin horizontal line through each little box indicates the degree of precision, i.e. how confident we can be in the estimate of the treatment effect – narrow horizontal lines through the boxes mean the data in support is large and consistently positive and is “statistically significant” in favor of the medicine. The wider the line, the less consistent, or less amount of data can be relied upon to make the estimate. When the horizontal line through a box extends across the vertical gray line, this indicates that it is statistically possible that the true estimate may actually be in favor of placebo!

With ivermectin, what sets it apart from all the other compounds tested, is the sheer number of randomized and observational controlled trials that have been performed to date. It is #1 among the “green box” compounds given it has been tested in 73 controlled trials which include an unheard-of 56,804 patients. Why unheard of? Because never in history has a medicine been so thoroughly tested, with such consistent positive results, yet led to a situation where governmental agencies in highly developed countries call for even more placebo-controlled trials to be done… and then slow walk to doing them. The ethics of giving a covid patient a placebo given this amount of supportive data are too miserable to contemplate this early in the article (fun fact – I was personally asked to try to help recruit patients for the ongoing University of Minnesota placebo controlled RCT. I got off the phone as fast as I could). Another not-so-fun fact: penicillin was mass deployed to great effect to all our troops for their battlefield injuries in World War II… based on a case series of 157 patients where their bacterial infections overtly resolved without signs of toxicity during treatment. Not one RCT was done before this decision was made by military and medical leaders.

The only other medicine with a larger supportive evidence base is hydroxychloroquine (HCQ), especially when only the early treatment trials of HCQ are considered as that collection of trials results in an equally impressive position on the Forest plot (not shown). A tired topic I will explore later is the much parroted (and highly favored by Pharma) notion that “retrospective, observational controlled trials (OCT)” cannot be trusted as they are inferior to “proper, large, double-blind, randomized, placebo controlled trials (RCT).” This notion is not evidence based. Even the captured (I know, sorry) Cochrane Library knows this. They themselves have shown that, on average, over thousands of clinical trials, over decades of research, OCT’s and RCT’s reach the same conclusions. So stop with the false dichotomy. Pharma wants you to only trust in “large RCT’s”… because they are the only ones with the cash to do them. That way, they can control the only medicines that get “proven” and thus adopted into guidelines.

Two absurdities (crimes) must be highlighted in the above diagram – one is the sheer number of medicines with demonstrated efficacy, most costing under $5 a dose (and almost all with unparalleled safety profiles and/or “over the counter” status) that are still not recommended by any U.S or “western” health agency (with the exception of the state of Florida since the hire of Surgeon General Dr. Joseph Ladapo who has put together a terrific public health campaign supporting the use of a combination early treatment protocol which includes another FLCCC adopted drug, fluvoxamine).

Meanwhile our federal governmental health agencies, which I have argued repeatedly (and will for years until it stops) are so completely captured by the pharmaceutical industry that they have not advocated for any one of these “repurposed” compounds, even as a “precautionary principle” (meaning that even if the purported benefits may not be realized to the extent estimated, the risks are so small it is more likely best for all we employ them now in early treatment given the world is cratering). Their most unforgivable and absurd inaction is the deliberate ignoring of the critical role of Vitamin D in protecting against the worst outcomes of COVID, despite knowing full well significant portions of the U.S population is Vitamin D deficient. Even Anthony Fauci recommends to himself that he take Vitamin D… regularly. The data below was given to me by a Dr. Henele and is from work he published in 2016. Note the percent of the U.S population that is critically deficient in Vitamin D.

The second absurdity is found when looking at the plot with only the medicines recommended in the NIH’s COVID protocol circled. Note that the NIH protocol is adhered to by almost the entirety of the country’s hospitals (largely due to large add-on bonuses paid to hospitals when the protocol elements are used – I am not making this up). A “theme” should begin to emerge as you look at the circled, “recommended” medicines vs the non-circled, “non-recommended” medicines – every single one is massively expensive. Every single one. Note not one inexpensive drug is circled. How much more evidence do you need to prove that our agencies have been completely captured by the pharmaceutical industry?

Fun fact now that you are en expert in reading Forest Plot’s: Merck’s mutagenic new drug molnupiravir, after the highly positive results from their study’s “interim analysis,” published in a press release, instead found that, in the 2nd half of its one study, the data favored… placebo. Thus if the 2nd half was a stand-alone study (which it arguably could have been) it’s box would be firmly on the right side of the line. FDA still approved… while feigning concern. Unsurprising really.

Now, beyond the above 73 controlled trials supporting ivermectin, there are, in addition, numerous health ministries from around the world that deployed ivermectin in either the prevention or early treatment of COVID, among often very large populations. Each program’s report found that ivermectin use led to massive reductions in the need for hospitalization and/or death (Mexico CityUttar PradeshBrazilMisionesLa Pampas, PeruPhillipines, and Japan – I will do a deeper dive on these in a later post). The program in the city of Itajai, Brazil is both the largest study of ivermectin in the world (data from nearly 200,000 patients was carefully collected over a 6 month period) and most impressive. They found that, despite the fact that the 120,000 patients who agreed to take ivermectin every 15 days were older, fatter, and sicker than the approximately 37,000 that did not… they went to hospital 67% less frequently, and died 70% less frequently… from all causes, not just COVID. The issue with ivermectin as a therapeutic in COVID… has NOTHING to do with the science.

The issue with ivermectin is simply it’s price – it costs less than a $1 and represents the biggest threat to the immense and future profits of the pharmaceutical industry’s novel oral anti-viral drugs… as well as their vaccines.

The previous title holder of the largest threat to Pharma profits in COVID was the highly effective (and also anti-viral) drug hydroxychloroquine (HCQ). However, it lost that title after the 2020 war on HCQ was essentially won by Pharma (for now?), using tactics so sinister as to be unimaginable, and which I will not review here as that macabre war has already been expertly reviewed in incredible and highly referenced detail in the book “The Real Anthony Fauci” by Robert F. Kennedy Jr. His book, in my opinion, is a must read for all the globe’s citizens, as without it, no coherent understanding of the innumerable non-scientific actions and policies across the entirety of the developed (and majority of the undeveloped) world can be gained.

I must emphasize that ivermectin is just the latest drug under attack during Pharma’s long-standing (and highly successful) war on off-patent, “no-longer-obscenely-profitable” medicines. Books have been written about the numerous, and often criminal actions that Big Pharma has employed to replace older off-patent medicines with newer, highly profitable, and often poorly tested drugs with either prospectively known dangers or quickly discovered dangers which they then criminally suppress or distort to preserve profits. When science supporting older, off-patent, often “repurposed” medicines (particularly in the lucrative environment of a global pandemic) becomes “inconvenient” to the financial promise of newer agents, the industry employs what are called “Disinformation” tactics, first invented and perfected by the Tobacco Industry, and now used to great effect by the Pharmaceutical (and many other) industries. These tactics are brilliantly and succinctly summarized in an article called The Disinformation Playbook written by The Union for Concerned Scientists. I encourage all to read. The 5 main “plays” from the playbook are listed below. If you are at all versed in the ivermectin in COVID saga (many FLCCC followers are), it should be easy to quickly come up with numerous examples of each nefarious tactic. I give some hints below…

1) The “Fake”: Conduct counterfeit science and try to pass it off as legitimate research (Dr. Andrew Hill)

2) The “Blitz”: Harass scientists who speak out with results or views inconvenient for industry (attacks on FLCCC founders)

3) The “Diversion”: Manufacture uncertainty about science where little or none exists (Dr. Andrew Hill/captured high-impact journals)

4) The “Screen”: Buy credibility through alliances with academia or professional societies (i.e. high impact medical journal influences)

5) The “Fix”: Manipulate government officials or processes to inappropriately influence policy (i.e. capture the health agencies by creating “revolving doors” between Pharma and government to ensure total synchrony in objectives amongst their leaders)

Given the Disinformation Playbook was last updated in 2018, it does not include newer, more nefarious tactics that industries have been able to deploy since the historic consolidation of financial power by just 3 multi-trillion dollar investment funds (Black Rock, State Street, and Vanguard). These three corporations have now acquired influential or outright controlling investment stakes in nearly every major corporation in nearly every industry. These investment managers power, particularly the power held synchronously over media companies, social media companies, and the near entirety of the pharmaceutical industry, has allowed even more fearsome tactics to be used in the near-global suppression of the efficacy of ivermectin (and HCQ) as they now:

1) CENSOR any mentions of supportive evidence in corporate, (a.k.a. “legacy”) media. Note that, besides the influence of these investment manager overlords, the global censoring ability of media was greatly helped by the “Trusted News Initiative (TNI),” an obscene (and either naively misguided or completely corrupt) effort by the most powerful journalism organizations in the world to band together to try to control the spread of “mis-information”. Yes, professional journalists decided they needed to control information in a pandemic. I am not making this up. Would an appropriate analogy be that a bunch of physician leaders decided they needed to spread disease in a pandemic?

2) CENSOR any mentions or discussions of efficacy on almost all social media – see explicit youtube “community” policy below as the most unsubtle example:


3) RETRACT positive papers from impactful medical journals (3 fully peer-reviewed and highly supportive scientific reviews of ivermectin have been retracted, either immediately prior to or post-publication (I was the lead author on the first one with my FLCCC colleagues)

4) BLOCK review and publication of positive trials of ivermectin in major medical journals (in my now global network of ivermectin-expert and/or ivermectin study investigator colleagues, all lament how their positive clinical trials or papers were rejected for review from all the high-impact (captured) journals, with Dr. Eli Schwartz’s highly sophisticated, expertly conducted, and immensely positive study from Israel being one of the most illustrative examples

5) PUBLISH numerous “hit pieces” within high profile print media outlets discrediting the science and/or the scientists who support the medicine. This is actually an example of the already described “Blitz” tactic, but in 2021, during COVID, using total media control, it was deployed by a division of Howitzers. A more recent and relatable example of “the Diversion” tactic was when the NFL used media hit pieces to go after the scientists (and their inconvenient science) after they began publishing and disseminating data about the high rates and disastrous impacts of chronic traumatic encephalopathy in retired NFL players.

What I have found fascinating, is that for every planted hit piece article discrediting the mountain of evidence supporting ivermectin as a therapeutic, the FLCCC is actually rarely mentioned. But why? I think it is because the FLCCC is a sizeable group of highly published physicians and researchers (Professor Paul Marik is actually the most published practicing ICU physician in the history of the specialty). Thus, it’s hard (but not impossible) to call us “fringe.” The last thing they want to do is call attention to our high degree of credibility. Instead they seem to be trying to destroy it using separate hit pieces (among other tactics) which has led to the recent loss of employment for three founding FLCCC members (Drs. Marik, Meduri, and yours truly have been forced to leave jobs or had their exemplary clinical and research careers ended (Drs. Marik and Meduri). An article on ivermectin that does not mention our organization does so purposefully so as not to give attention to credible support for its use given we are considered the foremost clinical experts on the clinical use of ivermectin in COVID in the world.

6) employ a coordinated media-government agency PROPAGANDA campaign;

August 26th, 2021: Pharma used their CDC to send out a “health advisory” to all 50 state Departments of Health, which they then sent to all the physicians licensed in their respective states (a terrifying example of the immense destructive power of a federal agency captured by pharmaceutical industry interests). The bulletin both;

1) depicted ivermectin as a dangerous drug by deliberately exaggerating reports of calls to poison control centers

2) cited the meaningless fact that it “is not FDA approved for COVID” as a reason it should not be used, hoping doctors may not realize that “off-label” prescribing is both legal and encouraged… by the FDA.

Next, a quickly debunked (not quickly enough) planted media article in Rolling Stone appeared with an impressively click-bait-able headline describing emergency rooms so overflowing with ivermectin overdoses that our nation’s gunshot victims couldn’t get (obviously) needed care (even I clicked on it). The article then went viral across the world (thousands of media mentions) before the hospital could put out a statement saying it was 100% false. Gee, do you think Pharma hired a professional PR firm to pull that one off or did they just benefit from a serendipitous and lamentably lazy journalist’s error?

Then, in another terrifying example of the control of major corporate media… for week after week every news broadcaster, pundit, and late-night talk show host prefaced the word ivermectin with the descriptor “horse de-wormer.” Over and over and over again (totally pissing off Joe Rogan who recovered from COVID with ivermectin as part of his combination protocol- hah!)

Then finally, in a coup de grace, in comes Pharma’s FDA proudly using twitter to associate ivermectin with, you guessed it, horses. Janet Woodcock, the acting Commissioner of the FDA, even sent out a congratulatory email to her team about the success of the tweet.

Was this a coordinated attack led by an expert team of brazen PR professionals who have a fondness for horses… or did it arise organically via a series of disconnected events?

If you are still not convinced of the former, I need to point out that this “series of disconnected events” had an uncanny sense of when to “roll-out.” The CDC’s Health Advisory was issued on August 26th. Look at the below chart and see if you can find any reason why it would start then? Recall that the advisory was ostensibly in reaction to false “reports of calls to poison control centers”. The below chart shows instead what was really going on at the time – hundreds, if not thousands of licensed medical professionals across the country were prescribing ivermectin like mad during the terrible, and deadly summer surge of the Delta variant. Was someone getting nervous that a “dirty little secret” was being rapidly discovered by American citizens and physicians? The answer is a definitive yes – thus triggering Pharma to nefariously try to “stuff the genie back in the bottle” by unleashing their terrifying disinformation propaganda campaign.


But check this out… the good ole’ FLCCC, my little band of brothers and sisters, is somehow making a opening in the wall of information suppression and distortion as shown in the chart below (compiled by our data analyst and ivermectin expert, Juan Chamie). I say this makes us “the Bad News Bears” in the repurposed drug war.

I am going to stop here… and call it PART I. Please subscribe below so you can be sure to get Part II where I will continue to detail the numerous and wide-ranging corrupt actions taken to suppress the knowledge of efficacy and restrict the use of ivermectin… across the world. There is way way more to this story.

Also, please be aware of the following events:

World-wide Rally for Freedom Day

Join us for a march in DC on defeating the mandate and to march in support of our international colleagues- who are also rallying on this day: Sunday January 23rd. 

United we stand, in peace we watch. Bring friends and jackets.

Go to for details

Finally, I am honored to have been invited by Dr. Chris Martenson and Peak Prosperity to their Annual Seminar as part of a speaker panel including some powerhouse thought leaders. Don’t miss it folks. Register using this link:

January 9, 2022 Posted by | Corruption, Deception, Fake News, Full Spectrum Dominance, Mainstream Media, Warmongering, Timeless or most popular, War Crimes | , | 1 Comment

Praise the Lord and Pass the Ivermectin

By Joel S Hirschhorn | January 2, 2022

With over 1,200 daily COVID deaths for many weeks the US is on track to reach a total of one million COVID related deaths by the end of March. A shameful record for 2022.

To think that every week over 8,000 Americans are dying, mostly in hospital ICUs is unbelievable. But that is no excuse that there is no serious attention by the mainstream media.  Take a moment to reflect that this is more deaths than those in the 9/11 attacks and Pearl Harbor, combined. And it is happening every week.

The late stage problem

Hospitals have become killing machines, places where the kiss of death is a protocol following government guidelines. Despite wide COVID vaccine use deaths in hospitals because of late stage viral infection remain at a high level. Difficulty in getting COVID testing quickly and often probably contributes to the high death rate. Too many people do not get their COVID infection addressed early. There remains too little use of monoclonal antibodies early for infected people. So their infection progresses to serious lung and breathing problems. That is the beginning of the end.

And it will be a long time before the new antiviral drugs from Pfizer and Merck are broadly available and there will be more information on whether they are really safe and effective for all diverse types of people.

In hospitals, patients with breathing problems and upper respiratory distress are giving medical actions that may address pain but inevitably lead to death, often after many weeks in the ICU. They get the useless and harmful drug remdesivir, supplemental oxygen, steroids, and are intubated, put on a ventilator and usually put into a coma.  And eventually they die and become another COVID statistic.

It has been reported that the death rate for COVID patients prescribed remdesivir (26%) exceeds the fatality rate of COVID patients prescribed ivermectin, which is recorded by the Medicare database at 7.2%. And it has documented serious side effects.

In a few successful court actions, such late stage COVID patients were given the cheap, safe generic IVM and – much to the astonishment of hospital doctors – have walked out of the hospital, completely recovered.

And there is considerable medical research literature supporting such use of IVM, principally because of its anti-inflammatory property. As just one example, a published medical 2021 hospital study found nearly a 50% reduction in deaths for patients with severe pulmonary involvement, the typical late stage COVID death-bed patient condition.  The many doubters of IVM should pay more attention to the medical science literature.

But published medical articles are ignored by the medical and public health establishments.

Hospital shame

Hospitals stubbornly refuse to honor the few court decisions directing them to give death-bed late COVID stage patients a chance of surviving by administering ivermectin.  Hospitals use an army of lawyers and every dirty legal trick to overturn or delay those few court decisions that reach the sensible conclusion that there is nothing to lose by using ivermectin.

Indeed, here is the ugly truth: Hospital protocols for late stage COVID patients have nearly a one hundred percent record of failure. Their patients suffer and then die.  Families desperate to get ivermectin used usually fail and watch their loved ones die.

This is a medical disgrace. This is the power of corporate medicine. This situation exemplifies the loss of medical freedom. This is the epitome of medical tyranny. This is a total loss of medical ethics. This is an extreme example of doctors failing to live up to their Hippocratic Oath. They follow hospital rules and let their patients die without trying what has a medical justification. Without doing what other doctors have successfully done.

Apparently, that weekly death total is not enough to push hospitals and doctors to use what several nations have used to curb the COVID pandemic and save many millions of lives.

Hospital care arguments

Consider this paradox and hypocrisy. Virtually all hospitals put a priority on patient centered care. Patient-centered care focuses on the patient and the individual’s particular health care needs. The goal of patient-centered health care is to empower patients to become active participants in their care.

Clearly, denying patient and family pleas for using ivermectin for people facing death is totally inconsistent with this philosophy and hospital commitment.

Add to all this that demanding all patients use a one-size-fits-all medical treatment or hospital protocol is also counter to personalized medicine, long the hallmark of medicine.  Doctors need the freedom to use what suits their patient rather than what the government dictates or accepting what it withholds.

Court actions to get hospitals allowing IVM use might be more successful if both patient centered care and personalized medicine arguments were presented to judges.


Time to let those who want to use ivermectin in an attempt to save their life get it. It is medically and morally the right thing to do.

With now a long record of hospital protocols for late stage COVID utterly failing to save lives, how can the medical profession justify not using a generic medicine that both research and clinical results justify and explain its ability to save lives?

They cannot.

Families trying to find a lawyer and a friendly court face a very, very difficult race to save their loved one stuck in the ICU just like a prisoner sentenced to death.

Is it COVID killing these people or the medical profession and their hospital employers? Worth pondering as you keep watching mounting COVID death numbers.

January 2, 2022 Posted by | Civil Liberties, Science and Pseudo-Science, Timeless or most popular, War Crimes | , , , | 1 Comment